Medullary Thyroid Carcinoma and Clinical Outcomes in Heterozygous Carriers of the RET K666N Germline Pathogenic Variant is a research paper published in JCEM Case Reports (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: K08DK129829
National Institutes of Health
Grant: 5K08DK129829-03
Mechanisms of Thyroid Autoimmunity in Checkpoint Immunotherapy
FWCI
0.65
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals